Replies to post #688073 on NorthWest Biotherapeutics Inc (NWBO)

[dennisdave]

As I have said here a few times I think NWBO will be bought for a price between $15 billion on the low end
https://www.biopharmadive.com/news/merck-dealmaking-15-billion-keytruda-cliff-davis/706309/

Merck keeps deal focus with Keytruda patent cliff on horizon The company is open to acquisitions of up to $15 billion, company CEO Rob Davis said

and $21 billion on the more realistic higher-end
https://www.gilead.com/news-and-press/press-room/press-releases/2020/9/gilead-sciences-to-acquire-immunomedics

Gilead Sciences, Inc. (Nasdaq: GILD) and Immunomedics (Nasdaq: IMMU) announced today that the companies have entered into a definitive agreement pursuant to which Gilead will acquire Immunomedics for $88.00 per share in cash. The transaction, which values Immunomedics at approximately $21 billion, was unanimously approved by both the Gilead and Immunomedics Boards of Directors and is anticipated to close during the fourth quarter of 2020.